Skip to main content
EU-Startups· Rahul Raj·· 11 days agoTop DealsAI Score71

Oxford spin-out Alethio Therapeutics raises €80.46M Series A for targeted blood cancer therapies

Oxford spin-out Alethio Therapeutics raises €80.46 million Series A to advance targeted blood cancer therapies

AI Overview

Alethio Therapeutics, an Abingdon-on-Thames biopharma spun out of the University of Oxford in 2021.

Why it matters

The round's syndicate and the ATX-011 timeline show how a University of Oxford spin-out is moving a targeted MPN antibody toward Phase 1/2a.

Source:EU-Startups · eu-startups.com

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing